BTK drives neutrophil activation for sterilizing antifungal immunity
Jigar V Desai,Marissa A Zarakas,Andrew L Wishart,Mark Roschewski,Mariano A Aufiero,Ágnes Donkó,Gustaf Wigerblad,Neta Shlezinger,Markus Plate,Matthew R James,Jean K Lim,Gulbu Uzel,Jenna Re Bergerson,Ivan Fuss,Robert A Cramer,Luis M Franco,Emily S Clark,Wasif N Khan,Daisuke Yamanaka,Georgios Chamilos,Jamel El-Benna,Mariana J Kaplan,Louis M Staudt,Thomas L Leto,Steven M Holland,Wyndham H Wilson,Tobias M Hohl,Michail S Lionakis
DOI: https://doi.org/10.1172/JCI176142
2024-05-02
Abstract:We describe a previously-unappreciated role for Bruton's tyrosine kinase (BTK) in fungal immune surveillance against aspergillosis, an unforeseen complication of BTK inhibitors (BTKi) used for treating B-cell lymphoid malignancies. We studied BTK-dependent fungal responses in neutrophils from diverse populations, including healthy donors, BTKi-treated patients, and X-linked agammaglobulinemia patients. Upon fungal exposure, BTK was activated in human neutrophils in a TLR2-, Dectin-1-, and FcγR-dependent manner, triggering the oxidative burst. BTK inhibition selectively impeded neutrophil-mediated damage to Aspergillus hyphae, primary granule release, and the fungus-induced oxidative burst by abrogating NADPH oxidase subunit p40phox and GTPase RAC2 activation. Moreover, neutrophil-specific Btk deletion in mice enhanced aspergillosis susceptibility by impairing neutrophil function, not recruitment or lifespan. Conversely, GM-CSF partially mitigated these deficits by enhancing p47phox activation. Our findings underline the crucial role of BTK signaling in neutrophils for antifungal immunity and provide a rationale for GM-CSF use to offset these deficits in susceptible patients.